Campus Review The latest in higher education news
The partnership between a Brisbane biotechnology company formed by The University of Queensland's Institute for Molecular Bioscience (IMB) and a publicly traded pharmaceutical company based on the east coast of the United States is expanding.
Please login below to view content or subscribe now.
Membership Login
Get the news delivered straight to your inbox
Receive the top stories in our weekly newsletter Sign up now